Russo V; Zompatori M; Galiè N, Extensive right pulmonary artery dissection in a young patient with chronic pulmonary hypertension, «HEART», 2012, 98, pp. 264 - 266 [articolo]
Manes A; Palazzini M; Dardi F; D'Adamo A; Rinaldi A; Galie' N, Genere femminile e ipertensione arteriosa polmonare: una relazione complessa
Female gender and pulmonary arterial hypertension: a complex relationship, «GIORNALE ITALIANO DI CARDIOLOGIA», 2012, 13, pp. 448 - 460 [articolo]
Galié N; Hoeper MM; Humbert M; Torbicki A; Vachiery JL; Barbera JA; Beghetti M; Corris P; Gaine S; Gibbs JS; Gomez-Sanchez MA; Jondeau G; Klepetko W; Opitz C; Peacock A; Rubin L; Zellweger M; Simonneau G; Vahanian A; Auricchio A; Bax J; Ceconi C; Dean V; Filippatos G; Funck-Brentano C; Hobbs R; Kearney P; McDonagh T; McGregor K; Popescu BA; Reiner Z; Sechtem U; Sirnes PA; Tendera M; Vardas P; Widimsky P., Guidelines for the diagnosis and treatment of pulmonary hypertension
Orientações para o diagnóstico e tratamento da hipertensão pulmonar, «REVISTA PORTUGUESA DE CARDIOLOGIA», 2012, 31, pp. 71 - 115 [articolo]
Modolon C; Attinà D; Buia F; De Luca F; Fughelli P; Bacchi Reggiani ML; Palazzini M; Manes A; Leci E; Galiè N; Zompatori M, Lung neovascularity in pulmonary arterial hypertension associated with congenital heart defects and idiopathic pulmonary arterial hypertension: study of 198 patients, «EUROPEAN RADIOLOGY», 2012, 22, pp. 1059 - 1066 [articolo]
Tapson VF; Torres F; Kermeen F; Keogh AM; Allen RP; Frantz RP; Badesch DB; Frost AE; Shapiro SM; Laliberte K; Sigman J; Arneson C; Galiè N, Oral Treprostinil for the Treatment of Pulmonary Arterial Hypertension in Patients on Background Endothelin Receptor Antagonist and/or Phosphodiesterase Type 5 Inhibitor Therapy (The FREEDOM-C Study): A Randomized Controlled Trial, «CHEST», 2012, 142, pp. 1383 - 1390 [articolo]
Simonneau G; Torbicki A; Hoeper MM; Delcroix M; Karlócai K; Galiè N; Degano B; Bonderman D; Kurzyna M; Efficace M; Giorgino R; Lang IM, Selexipag, an oral, selective IP receptor agonist for the treatment of pulmonary arterial hypertension, «EUROPEAN RESPIRATORY JOURNAL», 2012, 40, pp. 874 - 880 [articolo]
Konstantinides SV; Meyer G; Lang I; Verschuren F; Meyer G; Meneveau N; Charbonnier B; Bouvaist H; Geibel A; Beyer-Westendorf J; Dellas C; Empen K; Kupatt C; Galiè N; Giancarlo; Becattini C; Salvi A; Pruszczyk P; Torbicki A; Franca A; Lohmann C; Kozak M; Jiménez D; Kucher N; Goldhaber SZ; Danays T; Bluhmki E; Gallula P., Single-bolus tenecteplase plus heparin compared with heparin alone for normotensive patients with acute pulmonary embolism who have evidence of right ventricular dysfunction and myocardial injury: rationale and design of the Pulmonary Embolism Thrombolysis (PEITHO) trial, «AMERICAN HEART JOURNAL», 2012, 163, pp. 33 - 38 [articolo]
Attinà D; Valentino M; Galiè N; Modolon C; Buia F; de Luca F; Bacchi-Reggiani ML; Zompatori M., Application of a new pulmonary artery obstruction score in the prognostic evaluation of acute pulmonary embolism: comparison with clinical and haemodynamic parameters [Applicazione di un nuovo score di ostruzione vascolare nella valutazione prognostica dell'embolia polmonare acuta. Confronto con i parametri clinico-emodinamici], «LA RADIOLOGIA MEDICA», 2011, 116, pp. 230 - 245 [articolo]
Galie' N; Manes A; Palazzini M; Leci E, Conventional Medical Therapies in the treatment of pulmonary hypertension, in: PEACOCK A NAEIJE R RUBIN L, Pulmonary Hypertension, LONDON, Hadder Arnold, 2011, pp. 303 - 313 [capitolo di libro]
Lau EM; Manes A; Celermajer DS; Galiè N., Early detection of pulmonary vascular disease in pulmonary arterial hypertension: time to move forward., «EUROPEAN HEART JOURNAL», 2011, 32, pp. 2489 - 2498 [articolo]
Jing ZC; Yu ZX; Shen JY; Wu BX; Xu KF; Zhu XY; Pan L; Zhang ZL; Liu XQ; Zhang YS; Jiang X; Galiè N, Efficacy and Safety of Vardenafil in the Treatment of Pulmonary Arterial Hypertension (EVALUATION) Study Group. Vardenafil in pulmonary
arterial hypertension: a randomized, double-blind, placebo-controlled study, «AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE», 2011, 183, pp. 1723 - 1729 [articolo]
Renzulli M, Lucidi V, Gotti E, Mosconi C, Galiè N, Golfieri R, Gd-EOB-DTPA-enhanced MRI of the liver in pre-capillary pulmonary hypertension: incidence of Large regenerative Nodules (LRN). Preliminary data, «HEPATOLOGY INTERNATIONAL», 2011, 5, pp. 480 - 480 [abstract]
Galiè N; Hoeper MM; Simon J; Gibbs R; Simonneau G; Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS)., Liver toxicity of sitaxentan in pulmonary arterial hypertension., «EUROPEAN HEART JOURNAL», 2011, 32, pp. 386 - 387 [articolo]
Galiè N; Hoeper MM; Gibbs JS; Simonneau G, Liver toxicity of sitaxentan in pulmonary arterial hypertension., «EUROPEAN RESPIRATORY JOURNAL», 2011, 37, pp. 475 - 476 [replica/breve intervento]
Rubin LJ; Badesch DB; Fleming TR; Galiè N; Simonneau G; Ghofrani HA; Oakes M; Layton G; Serdarevic-Pehar M; McLaughlin VV; Barst RJ; behalf of the SUPER-2 Study Group., Long-term Treatment With Sildenafil Citrate in Pulmonary Arterial Hypertension: The SUPER-2 Study., «CHEST», 2011, 140, pp. 1274 - 1283 [articolo]
